News & Events about Igm Biosciences Inc.
Execution of the annual general meeting's resolution on the removal of share class in Medivir AB (publ) Execution of the annual general meeting's resolution on the removal of share class in Medivir AB (publ) PR Newswire STOCKHOLM, May 4, 2023 STOCKHOLM, May 4, 2023 /PRNewswire/ --The annual general...
Resolutions at the Annual General Meeting in Medivir on 4 May 2023 Resolutions at the Annual General Meeting in Medivir on 4 May 2023 PR Newswire STOCKHOLM, May 4, 2023 STOCKHOLM, May 4, 2023 /PRNewswire/ --Medivir Aktiebolag (publ) held its annual general meeting today on 4 May 2023. The annual...
Medivir presents new data at AACR showing significantly improved antitumor efficacy in non-clinical tumor models with fostrox in triple combination Medivir presents new data at AACR showing significantly improved antitumor efficacy in non-clinical tumor models with fostrox in triple combination PR...
Medivir 2022 Annual Report published Medivir 2022 Annual Report published PR Newswire STOCKHOLM, April 4, 2023 STOCKHOLM, April 4, 2023 /PRNewswire/ -- Medivir AB (NASDAQ Stockholm: MVIR)today announces that the Annual Report for 2022 now is available at the company's website: www.medivir.com...
Notice of Annual General Meeting of Medivir AB (publ) Notice of Annual General Meeting of Medivir AB (publ) PR Newswire STOCKHOLM, March 31, 2023 STOCKHOLM, March 31, 2023 /PRNewswire/ --The shareholders of Medivir AB (publ), reg. no. 556238-4361, with its registered office in Huddinge, Stockholm...